Natera (NTRA) is down 3.6% today. Here is some analysis on what might have caused this price movement.
Analysis: The most likely explanation is a mix of profit-taking and a softer reaction to recent insider sale disclosures rather than a clear fundamental setback. This could be because there does not appear to be a major negative business update tied directly to today’s move, even as investors weigh insider selling notices and position ahead of the company’s next earnings report.
Details:
A recent Form 144 filing disclosed a proposed sale of Natera shares by an insider, which can pressure sentiment even though these filings do not always lead to completed sales.There does not appear to be a fresh company announcement this week pointing to a material operational problem, product issue, or guidance cut.Natera’s latest reported quarter showed continued revenue growth, higher test volumes, and positive operating cash flow, which suggests today’s decline may be more about positioning than deteriorating fundamentals.Wall Street research published earlier this week still showed a constructive stance on the stock, including a higher price target from one firm, making the pullback look more like a near-term reset than a clear change in the broader thesis.Sources:
SEC, Natera, Benzinga, TipRanks
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$NTRA Insider Trading Activity
$NTRA insiders have traded $NTRA stock on the open market 258 times in the past 6 months. Of those trades, 0 have been purchases and 258 have been sales.
Here’s a breakdown of recent trading of $NTRA stock by insiders over the last 6 months:
- MATTHEW RABINOWITZ (EXECUTIVE CHAIRMAN) has made 0 purchases and 50 sales selling 308,708 shares for an estimated $61,652,899.
- STEVEN LEONARD CHAPMAN (CEO AND PRESIDENT) has made 0 purchases and 32 sales selling 226,953 shares for an estimated $51,860,218.
- DANIEL RABINOWITZ (SEC. AND CHIEF LEGAL OFFICER) has made 0 purchases and 35 sales selling 94,026 shares for an estimated $22,564,856.
- MICHAEL BURKES BROPHY (CHIEF FINANCIAL OFFICER) has made 0 purchases and 21 sales selling 79,769 shares for an estimated $18,738,853.
- ROELOF BOTHA has made 0 purchases and 6 sales selling 78,000 shares for an estimated $17,184,092.
- SOLOMON MOSHKEVICH (PRESIDENT, CLINICALDIAGNOSTICS) has made 0 purchases and 35 sales selling 50,504 shares for an estimated $11,458,574.
- JONATHAN SHEENA has made 0 purchases and 61 sales selling 30,779 shares for an estimated $6,547,529.
- JOHN FESKO (PRESIDENT, CHIEF BUS. OFFICER) has made 0 purchases and 11 sales selling 27,575 shares for an estimated $6,339,337.
- HERM ROSENMAN sold 16,530 shares for an estimated $4,132,500
- GAIL BOXER MARCUS has made 0 purchases and 4 sales selling 11,000 shares for an estimated $2,389,328.
- ROWAN E CHAPMAN has made 0 purchases and 2 sales selling 3,086 shares for an estimated $665,884.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
EARLY ACCESS
Receive NTRA Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →
$NTRA Hedge Fund Activity
We have seen 343 institutional investors add shares of $NTRA stock to their portfolio, and 335 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,312,887 shares (+12.1%) to their portfolio in Q1 2026, for an estimated $262,564,271
- FMR LLC added 1,078,266 shares (+73.1%) to their portfolio in Q1 2026, for an estimated $215,642,417
- FARALLON CAPITAL MANAGEMENT LLC removed 707,000 shares (-18.1%) from their portfolio in Q1 2026, for an estimated $141,392,930
- DUQUESNE FAMILY OFFICE LLC added 552,249 shares (+22.0%) to their portfolio in Q1 2026, for an estimated $110,444,277
- CASTLE HOOK PARTNERS LP added 361,941 shares (+16.7%) to their portfolio in Q1 2026, for an estimated $72,384,580
- DRIEHAUS CAPITAL MANAGEMENT LLC removed 341,574 shares (-54.6%) from their portfolio in Q1 2026, for an estimated $68,311,384
- MAPLELANE CAPITAL, LLC added 339,000 shares (+inf%) to their portfolio in Q1 2026, for an estimated $67,796,610
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$NTRA Government Contracts
We have seen $391,600 of award payments to $NTRA over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
$NTRA Analyst Ratings
Wall Street analysts have issued reports on $NTRA in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 06/23/2026
- William Blair issued a "Outperform" rating on 04/14/2026
To track analyst ratings and price targets for $NTRA, check out Quiver Quantitative's $NTRA forecast page.
$NTRA Price Targets
Multiple analysts have issued price targets for $NTRA recently. We have seen 12 analysts offer price targets for $NTRA in the last 6 months, with a median target of $270.0.
Here are some recent targets:
- Tejas Savant from Morgan Stanley set a target price of $310.0 on 07/09/2026
- Daniel Markowitz from Evercore ISI Group set a target price of $300.0 on 07/06/2026
- Subbu Nambi from Guggenheim set a target price of $290.0 on 06/29/2026
- Eve Burstein from Bernstein set a target price of $310.0 on 06/26/2026
- Luke Sergott from Barclays set a target price of $260.0 on 06/24/2026
- Mark Massaro from BTIG set a target price of $275.0 on 06/24/2026
- Dan Leonard from RBC Capital set a target price of $275.0 on 06/11/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Read full article here »
View the Zacks #1 Rank List
Why Natera (NTRA) Stock Is Down Today
Natera (NTRA) is down 3.6% today. Here is some analysis on what might have caused this price movement.
Analysis: The most likely explanation is a mix of profit-taking and a softer reaction to recent insider sale disclosures rather than a clear fundamental setback. This could be because there does not appear to be a major negative business update tied directly to today’s move, even as investors weigh insider selling notices and position ahead of the company’s next earnings report.
Details:
Sources:
SEC, Natera, Benzinga, TipRanks
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$NTRA Insider Trading Activity
$NTRA insiders have traded $NTRA stock on the open market 258 times in the past 6 months. Of those trades, 0 have been purchases and 258 have been sales.
Here’s a breakdown of recent trading of $NTRA stock by insiders over the last 6 months:
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$NTRA Hedge Fund Activity
We have seen 343 institutional investors add shares of $NTRA stock to their portfolio, and 335 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$NTRA Government Contracts
We have seen $391,600 of award payments to $NTRA over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
$NTRA Analyst Ratings
Wall Street analysts have issued reports on $NTRA in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
To track analyst ratings and price targets for $NTRA, check out Quiver Quantitative's $NTRA forecast page.
$NTRA Price Targets
Multiple analysts have issued price targets for $NTRA recently. We have seen 12 analysts offer price targets for $NTRA in the last 6 months, with a median target of $270.0.
Here are some recent targets:
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Read full article here »